Your session is about to expire
← Back to Search
Hyperpolarized 129Xenon gas for Pulmonary Vascular Disease
Study Summary
This trial will use 129Xe MRI and other techniques to study how well the lungs are ventilated and how well they exchange gases.
- Pulmonary Vascular Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many individuals are engaging in this medical experiment?
"Affirmative. Clinicaltrials.gov details that this investigation is currently enlisting participants, with the first posting on March 29th 2018 and last updated October 3rd 2022. The study seeks to enroll 12 individuals at a single research centre."
Is this research the inaugural effort of its kind?
"Since 2018, Hyperpolarized 129Xenon gas has been under investigation. The initial trial occurred in that same year and was funded by United Therapeutics; after the 12-patient study finished Phase 2 trials, a single active clinical experiment is being sponsored by United Therpeutics."
What other research studies have explored the use of Hyperpolarized 129Xenon gas?
"Currently, one active clinical trial exists for Hyperpolarized 129Xenon gas and none have reached Phase 3. This research is concentrated on Durham, North carolina but other medical centres are also participating in the study."
What risks are associated with Hyperpolarized 129Xenon gas treatment?
"Assessed at a rating of 2 on the 1 to 3 scale, our team concluded that Hyperpolarized 129Xenon gas is relatively safe as Phase 2 clinical trials have yielded promising safety results but no efficacy data."
Are there any remaining spots available for this research initiative?
"As attested by the clinicaltrials.gov website, this trial is actively enrolling participants. The study was first published on March 29th 2018 and underwent its most recent edit on October 3rd 2022."
Share this study with friends
Copy Link
Messenger